Tim-3 pathway affects NK cell impairment in patients with active tuberculosis

Cytokine

Volumn 76, Issue 2, 2015, Pages 270-279

  Wang, Feng ^a   Hou, Hongyan ^a   Wu, Shiji ^a   Tang, Qing ^a   Huang, Min ^a   Yin, Botao ^a   Huang, Jing ^a   Liu, Weiyong ^a   Mao, Lie ^a   Lu, Yanfang ^a   Sun, Ziyong ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

NK cells; Tim 3; Tuberculosis

Indexed keywords

ETHAMBUTOL; GAMMA INTERFERON; INTERLEUKIN 12; ISONIAZID; MEMBRANE PROTEIN; PROTEIN TIM 3; PYRAZINAMIDE; RIFAMPICIN; UNCLASSIFIED DRUG; HAVCR2 PROTEIN, HUMAN;

ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; DEGRANULATION; HUMAN; HUMAN CELL; LATENT TUBERCULOSIS; LUNG LAVAGE; LYMPHOCYTE FUNCTION; MACROPHAGE; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TUBERCULOSIS; UNIVERSITY HOSPITAL; BIOSYNTHESIS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; K562 CELL LINE; LYMPHOCYTE ACTIVATION; METABOLISM; MYCOBACTERIUM TUBERCULOSIS; PHYSIOLOGY;

CELL DEGRANULATION; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-12; K562 CELLS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MEMBRANE PROTEINS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

EID: 84943819704     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2015.05.012     Document Type: Article

References (41)

1. World Health Organization (WHO). Global tuberculosis report 2013.
2. Kaufmann S.H., Parida S.K. Tuberculosis in Africa: learning from pathogenesis for biomarker identification. Cell Host Microbe 2008, 4:219-228.
3. Chiang C.Y., Van Weezenbeek C., Mori T., Enarson D.A. Challenges to the global control of tuberculosis. Respirology 2013, 18:596-604.
4. Vankayalapati R., Barnes P.F. Innate and adaptive immune responses to human mycobacterium tuberculosis infection. Tuberculosis 2009, 89(Suppl. 1):S77-S80.
5. Vankayalapati R., Garg A., Porgador A., Griffith D.E., Klucar P., Safi H., et al. Role of NK cell-activating receptors and their ligands in the lysis of mononuclear phagocytes infected with an intracellular bacterium. J Immunol 2005, 175:4611-4617.
6. Vankayalapati R., Wizel B., Weis S.E., Safi H., Lakey D.L., Mandelboim O., et al. The NKp46 receptor contributes to NK cell lysis of mononuclear phagocytes infected with an intracellular bacterium. J Immunol 2002, 168:3451-3457.
7. Nirmala R., Narayanan P.R., Mathew R., Maran M., Deivanayagam C.N. Reduced NK activity in pulmonary tuberculosis patients with/without HIV infection: identifying the defective stage and studying the effect of interleukins on NK activity. Tuberculosis 2001, 81:343-352.
8. Ratcliffe L.T., Lukey P.T., MacKenzie C.R., Ress S.R. Reduced NK activity correlates with active disease in HIV- patients with multidrug-resistant pulmonary tuberculosis. Clin Exp Immunol 1994, 97:373-379.
9. Schierloh P., Aleman M., Yokobori N., Alves L., Roldan N., Abbate E., et al. NK cell activity in tuberculosis is associated with impaired CD11a and ICAM-1 expression: a regulatory role of monocytes in NK activation. Immunology 2005, 116:541-552.
10. Alvarez I.B., Pasquinelli V., Jurado J.O., Abbate E., Musella R.M., de la Barrera S.S., et al. Role played by the programmed death-1-programmed death ligand pathway during innate immunity against mycobacterium tuberculosis. J Inf Dis 2010, 202:524-532.
11. + alloreactive T cell and prolongs survival of skin graft. Cell Immunol 2007, 250:68-74.
12. Yang X., Jiang X., Chen G., Xiao Y., Geng S., Kang C., et al. T cell Ig mucin-3 promotes homeostasis of sepsis by negatively regulating the TLR response. J Immunol 2013, 190:2068-2079.
13. Ndhlovu L.C., Lopez-Verges S., Barbour J.D., Jones R.B., Jha A.R., Long B.R., et al. Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity. Blood 2012, 119:3734-3743.
14. Zhu C., Anderson A.C., Kuchroo V.K. TIM-3 and its regulatory role in immune responses. Curr Top Micro Immunol 2011, 350:1-15.
15. Zhu C., Anderson A.C., Schubart A., Xiong H., Imitola J., Khoury S.J., et al. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nature Immunol 2005, 6:1245-1252.
16. Joller N., Peters A., Anderson A.C., Kuchroo V.K. Immune checkpoints in central nervous system autoimmunity. Immunol Rev 2012, 248:122-139.
17. Kanzaki M., Wada J., Sugiyama K., Nakatsuka A., Teshigawara S., Murakami K., et al. Galectin-9 and T cell immunoglobulin mucin-3 pathway is a therapeutic target for type 1 diabetes. Endocrinology 2012, 153:612-620.
18. Wang F., He W., Yuan J., Wu K., Zhou H., Zhang W., et al. Activation of Tim-3-Galectin-9 pathway improves survival of fully allogeneic skin grafts. Transplant Immunol 2008, 19:12-19.
19. Sakuishi K., Apetoh L., Sullivan J.M., Blazar B.R., Kuchroo V.K., Anderson A.C. Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity. J Exp Med 2010, 207:2187-2194.
20. + T cells. J Virol 2009, 83:9122-9130.
21. Gleason M.K., Lenvik T.R., McCullar V., Felices M., O'Brien M.S., Cooley S.A., et al. Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9. Blood 2012, 119:3064-3072.
22. Henao-Tamayo M., Irwin S.M., Shang S., Ordway D., Orme I.M. T lymphocyte surface expression of exhaustion markers as biomarkers of the efficacy of chemotherapy for tuberculosis. Tuberculosis 2011, 91:308-313.
23. Wang X., Cao Z., Jiang J., Li Y., Dong M., Ostrowski M., et al. Elevated expression of Tim-3 on CD8 T cells correlates with disease severity of pulmonary tuberculosis. J Infect 2011, 62:292-300.
24. + T cells less susceptible to HIV-1 infection. Blood 2012, 119:4192-4204.
25. Fu X., Liu Y., Li L., Li Q., Qiao D., Wang H., et al. Human natural killer cells expressing the memory-associated marker CD45RO from tuberculous pleurisy respond more strongly and rapidly than CD45RO- natural killer cells following stimulation with interleukin-12. Immunology 2011, 134:41-49.
26. Dhiman R., Indramohan M., Barnes P.F., Nayak R.C., Paidipally P., Rao L.V., et al. IL-22 produced by human NK cells inhibits growth of mycobacterium tuberculosis by enhancing phagolysosomal fusion. J Immunol 2009, 183:6639-6645.
27. Tobian A.A., Potter N.S., Ramachandra L., Pai R.K., Convery M., Boom W.H., et al. Alternate class I MHC antigen processing is inhibited by Toll-like receptor signaling pathogen-associated molecular patterns: mycobacterium tuberculosis 19-kDa lipoprotein, CpG DNA, and lipopolysaccharide. J Immunol 2003, 171:1413-1422.
28. Millman A.C., Salman M., Dayaram Y.K., Connell N.D., Venketaraman V. Natural killer cells, glutathione, cytokines, and innate immunity against mycobacterium tuberculosis. J Interferon Cytokine Res: Official J Int Soc Interferon Cytokine Res 2008, 28:153-165.
29. Cooper M.A., Fehniger T.A., Caligiuri M.A. The biology of human natural killer-cell subsets. Trends Immunol 2001, 22:633-640.
30. Jain A.K. Tuberculosis of the spine: a fresh look at an old disease. J Bone Joint Surg Br Volume 2010, 92:905-913.
31. Wilson D., Badri M., Maartens G. Performance of serum C-reactive protein as a screening test for smear-negative tuberculosis in an ambulatory high HIV prevalence population. PloS One 2011, 6:e15248.
32. Sahiratmadja E., Alisjahbana B., Buccheri S., Di Liberto D., de Boer T., Adnan I., et al. Plasma granulysin levels and cellular interferon-gamma production correlate with curative host responses in tuberculosis, while plasma interferon-gamma levels correlate with tuberculosis disease activity in adults. Tuberculosis 2007, 87:312-321.
33. Gallois A., Silva I., Osman I., Bhardwaj N. Reversal of natural killer cell exhaustion by TIM-3 blockade. Oncoimmunology 2014, 3:e946365.
34. Hou N., Zhao D., Liu Y., Gao L., Liang X., Liu X., et al. Increased expression of T cell immunoglobulin- and mucin domain-containing molecule-3 on natural killer cells in atherogenesis. Atherosclerosis 2012, 222:67-73.
35. Seki S., Nakashima H., Nakashima M., Kinoshita M. Antitumor immunity produced by the liver Kupffer cells, NK cells, NKT cells, and CD8 CD122 T cells. Clin Dev Immunol 2011, 2011:868345.
36. Fu X., Yang B., Lao S., Fan Y., Wu C. Human memory-like NK cells migrating to tuberculous pleural fluid via IP-10/CXCR3 and SDF-1/CXCR4 axis produce IFN-gamma in response to Bacille Calmette Guerin. Clin Immunol 2013, 148:113-123.
37. Sun J.C., Lanier L.L. Versatility in NK cell memory. Immunol Cell Biol 2011, 89:327-329.
38. Zhao J., Lei Z., Liu Y., Li B., Zhang L., Fang H., et al. Human pregnancy up-regulates Tim-3 in innate immune cells for systemic immunity. J Immunol 2009, 182:6618-6624.
39. Nebbia G., Peppa D., Schurich A., Khanna P., Singh H.D., Cheng Y., et al. Upregulation of the Tim-3/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection. PloS One 2012, 7:e47648.
40. Jones R.B., Ndhlovu L.C., Barbour J.D., Sheth P.M., Jha A.R., Long B.R., et al. Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection. J Exp Med 2008, 205:2763-2779.
41. Klibi J., Niki T., Riedel A., Pioche-Durieu C., Souquere S., Rubinstein E., et al. Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells. Blood 2009, 113:1957-1966.